Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.

R I Breuer, K H Soergel, B A Lashner, M L Christ, S B Hanauer, A Vanagunas, J M Harig, A Keshavarzian, M Robinson, J H Sellin, D Weinberg, D E Vidican, K L Flemal, A W Rademaker

Evanston Hospital, Division of Gastroenterology, Evanston, Illinois 60201, USA.

BACKGROUND: Short chain fatty acid (SCFA) deficiency is associated with colitis in animals and humans, and the mucosal metabolism of these compounds is decreased in ulcerative colitis. AIMS: To assess the efficacy of topical SCFA treatment in ulcerative colitis. PATIENTS AND METHODS: 103 patients with distal ulcerative colitis were entered into a six week, double-blind, placebo controlled trial of rectal SCFA twice daily; patients who were unchanged on placebo were offered SCFA in an open-label extension trial. RESULTS: Of the 91 patients completing the trial, more patients in the SCFA treated than in the placebo treated group improved (33% v 20%, p = 0.14, NS). Those on SCFA also had larger, but statistically non-significant, reductions in every component of their clinical and histological activity scores. In patients with a relatively short current episode of colitis (< 6 months, n = 42), more responded to SCFA than to placebo (48% v 18%, p = 0.03). These patients also had larger, but statistically non-significant, decreases in their clinical activity index (p = 0.08 v placebo). Every patient who improved used at least five of six of the prescribed rectal SCFA irrigations, whereas only 37% who did not improve were as compliant. In the open-label extension trial, 65% improved on SCFA; these patients also had significant reductions (p < 0.02) in their clinical and histological activity scores. CONCLUSIONS: Although SCFA enemas were not of therapeutic value in this controlled trial, the results suggest efficacy in subsets of patients with distal ulcerative colitis including those with short active episodes. Prolonged contact with rectal mucosa seems to be necessary for therapeutic benefit.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wong, J. M. W., Jenkins, D. J. A. (2007). Carbohydrate Digestibility and Metabolic Effects. J. Nutr. 137: 2539S-2546S [Abstract] [Full Text]  
• Williams, L., Armstrong, M., Finan, P., Sagar, P., Burke, D. (2007). The effect of faecal diversion on human ileum. Gut 56: 796-801 [Abstract] [Full Text]  
• Gill, R. K., Saksena, S., Alrefai, W. A., Sarwar, Z., Goldstein, J. L., Carroll, R. E., Ramaswamy, K., Dudeja, P. K. (2005). Expression and membrane localization of MCT isoforms along the length of the human intestine. Am. J. Physiol. Cell Physiol. 289: C846-C852 [Abstract] [Full Text]  
• Farrell, R. J. (2003). Epidermal Growth Factor for Ulcerative Colitis. NEJM 349: 395-397 [Full Text]  
• Keshavarzian, A, Banan, A, Farhadi, A, Komanduri, S, Mutlu, E, Zhang, Y, Fields, J Z (2003). Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52: 720-728 [Abstract] [Full Text]  
• Cherbut, C., Michel, C., Lecannu, G. (2003). The Prebiotic Characteristics of Fructooligosaccharides Are Necessary for Reduction of TNBS-Induced Colitis in Rats. J. Nutr. 133: 21-27 [Abstract] [Full Text]  
• Rodriguez-Cabezas, M. E., Galvez, J., Lorente, M. D., Concha, A., Camuesco, D., Azzouz, S., Osuna, A., Redondo, L., Zarzuelo, A. (2002). Dietary Fiber Down-Regulates Colonic Tumor Necrosis Factor {alpha} and Nitric Oxide Production in Trinitrobenzenesulfonic Acid-Induced Colitic Rats. J. Nutr. 132: 3263-3271 [Abstract] [Full Text]  
• Tyagi, S., Venugopalakrishnan, J., Ramaswamy, K., Dudeja, P. K. (2002). Mechanism of n-butyrate uptake in the human proximal colonic basolateral membranes. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G676-G682 [Abstract] [Full Text]  
• Pender, S. L. F., Quinn, J. J., Sanderson, I. R., MacDonald, T. T. (2000). Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G918-G924 [Abstract] [Full Text]  
• Pitcher, M C L, Beatty, E R, Cummings, J H (2000). The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46: 64-72 [Abstract] [Full Text]  
• Jenkins, D. J.A., Kendall, C. W.C., Vuksan, V., Augustin, L. S.A., Li, Y.-M., Lee, B., Mehling, C. C., Parker, T., Faulkner, D., Seyler, H., Vidgen, E., Fulgoni, V. III (1999). The Effect of Wheat Bran Particle Size on Laxation and Colonic Fermentation. J. Am. Coll. Nutr. 18: 339-345 [Abstract] [Full Text]  
• Ohno, Y., Lee, J., Fusunyan, R. D., MacDermott, R. P., Sanderson, I. R. (1997). Macrophage inflammatory protein-2: Chromosomal regulation in rat small intestinal epithelial cells. Proc. Natl. Acad. Sci. USA 94: 10279-10284 [Abstract] [Full Text]